This is in line with studies indicating STC2's involvement in CRC progression that STC2 is an independent prognostic marker of overall survival in CRC and knockdown of STC2 can inhibit CRC cell migration13, 28. This evidence concerns the gene STC2 and colorectal carcinoma.